Aquestive Therapeutics, Inc. (AQST)
6.23
+0.13
(+2.13%)
USD |
NASDAQ |
Dec 10, 16:00
6.22
-0.01
(-0.16%)
After-Hours: 20:00
Aquestive Therapeutics Free Cash Flow: -50.94M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Intuitive Surgical, Inc. | 2.271B |
| Eli Lilly & Co. | 6.436B |
| Madrigal Pharmaceuticals, Inc. | -164.63M |
| TransCode Therapeutics, Inc. | -14.52M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.65M |
| Cash from Investing (Quarterly) | -0.235M |
| Cash from Financing (Quarterly) | 81.41M |
| Free Cash Flow Per Share (Quarterly) | -0.1165 |
| Free Cash Flow to Equity (Quarterly) | -15.49M |
| Free Cash Flow to Firm (Quarterly) | -8.611M |
| Free Cash Flow Yield | -8.25% |